| Dopamine transporter density in patients with attention deficit hyperactivity disorder DD Dougherty, AA Bonab, TJ Spencer, SL Rauch, BK Madras, ... The Lancet 354 (9196), 2132-2133, 1999 | 960 | 1999 |
| Screening, brief interventions, referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites: comparison at intake and 6 months later BK Madras, WM Compton, D Avula, T Stegbauer, JB Stein, HW Clark Drug and alcohol dependence 99 (1-3), 280-295, 2009 | 868 | 2009 |
| Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys. J Bergman, BK Madras, SE Johnson, RD Spealman The Journal of pharmacology and experimental therapeutics 251 (1), 150-155, 1989 | 563 | 1989 |
| The dopamine transporter and attention-deficit/hyperactivity disorder BK Madras, GM Miller, AJ Fischman Biological psychiatry 57 (11), 1397-1409, 2005 | 494 | 2005 |
| 1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors PC Meltzer, D Butler, JR Deschamps, BK Madras Journal of medicinal chemistry 49 (4), 1420-1432, 2006 | 397 | 2006 |
| Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro BK Madras, Z Xie, Z Lin, A Jassen, H Panas, L Lynch, R Johnson, E Livni, ... The Journal of pharmacology and experimental therapeutics 319 (2), 561-569, 2006 | 376 | 2006 |
| Effects of cocaine and related drugs in nonhuman primates. I.[3H] cocaine binding sites in caudate-putamen. BK Madras, MA Fahey, J Bergman, DR Canfield, RD Spealman The Journal of pharmacology and experimental therapeutics 251 (1), 131-141, 1989 | 357 | 1989 |
| Cocaine receptors labeled by [3H] 2 beta-carbomethoxy-3 beta-(4-fluorophenyl) tropane. BK Madras, RD Spealman, MA Fahey, JL Neumeyer, JK Saha, RA Milius Molecular Pharmacology 36 (4), 518-524, 1989 | 355 | 1989 |
| Anti-hyperactivity medication: methylphenidate and amphetamine P Seeman, BK Madras Molecular psychiatry 3 (5), 386-396, 1998 | 349 | 1998 |
| Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's‐diseased striatum MJ Kaufman, BK Madras Synapse 9 (1), 43-49, 1991 | 328 | 1991 |
| Polymorphisms in the 3′-untranslated region of human and monkey dopamine transporter genes affect reporter gene expression GM Miller, BK Madras Molecular psychiatry 7 (1), 44-55, 2002 | 299 | 2002 |
| PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short-and long-acting oral methylphenidate TJ Spencer, J Biederman, P E. Ciccone, BK Madras, DD Dougherty, ... American Journal of Psychiatry 163 (3), 387-395, 2006 | 283 | 2006 |
| In vivo neuroreceptor imaging in attention-deficit/hyperactivity disorder: a focus on the dopamine transporter TJ Spencer, J Biederman, BK Madras, SV Faraone, DD Dougherty, ... Biological psychiatry 57 (11), 1293-1300, 2005 | 278 | 2005 |
| Asparagine synthetase activity of mouse leukemias B Horowitz, BK Madras, A Meister, LJ Old, EA Boyse, E Stockert Science 160 (3827), 533-535, 1968 | 273 | 1968 |
| MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment CD Verrico, GM Miller, BK Madras Psychopharmacology 189, 489-503, 2007 | 254 | 2007 |
| Further evidence of dopamine transporter dysregulation in ADHD: a controlled PET imaging study using altropane TJ Spencer, J Biederman, BK Madras, DD Dougherty, AA Bonab, E Livni, ... Biological psychiatry 62 (9), 1059-1061, 2007 | 222 | 2007 |
| Effects of cocaine and related drugs in nonhuman primates. II. Stimulant effects on schedule-controlled behavior. RD Spealman, BK Madras, J Bergman The Journal of pharmacology and experimental therapeutics 251 (1), 142-149, 1989 | 207 | 1989 |
| Relevance of free tryptophan in serum to tissue tryptophan concentrations BK Madras, EL Cohen, R Messing, HN Munro, RJ Wurtman Metabolism 23 (12), 1107-1116, 1974 | 204 | 1974 |
| Improving access to evidence-based medical treatment for opioid use disorder: strategies to address key barriers within the treatment system BK Madras, NJ Ahmad, J Wen, JS Sharfstein NAM perspectives 2020, 10.31478/202004b, 2020 | 195 | 2020 |
| Methylphenidate elevates resting dopamine which lowers the impulse-triggered release of dopamine: a hypothesis P Seeman, B Madras Behavioural brain research 130 (1-2), 79-83, 2002 | 186 | 2002 |
